Case Studies the Wonderful World of Weirdobacter Weirdii Species!

Case Studies the Wonderful World of Weirdobacter Weirdii Species!

10/11/19 Case Studies Lars F. Westblade, Ph.D, D(ABMM) (E-mail: [email protected]) Weill Cornell Medicine SCASM, San Diego October 26, 2019 1 1 The Wonderful World of Weirdobacter weirdii species! Lars F. Westblade, Ph.D, D(ABMM) (E-mail: [email protected]) Weill Cornell Medicine SCASM, San Diego October 26, 2019 2 2 1 10/11/19 Disclosures • Grant/Research suPPort: - Accelerate Diagnostics, Inc. - BioFire Diagnostics, LLC - Hardy Diagnostics • Advisory Board: - Roche Molecular Systems, Inc. 3 3 Objectives • List diagnostic features of microorganisms not commonly encountered or recognized in the clinical microbiology laboratory • Describe their significance and clinical Presentation • Discuss their key antimicrobial suscePtibility traits 4 4 2 10/11/19 What are Weirdobacter weirdii Species? • Organisms rarely encountered or recognized in the clinical microbiology laboratory à be at the ready! • Can be difficult to identify using biochemical methods • Provide oPPortunity for inane trivia! 5 5 Case 1: Color Me Bad • 11-year-old male from Alabama Presents to regional community hospital with gluteal abscess • Had been standing in stagnant water • Oral (PO) clindamycin administered as outPatient 2 days Lesions ~2 cm in diameter 6 Richard et al., 2015 Am J Case Rep 16:740-4 6 3 10/11/19 Case 1: Color Me Bad • Within 24 h develoPed fever and admitted to local community hospital for surgical drainage of Presumed Staphylococcus aureus soft tissue infection • Intravenous (IV) clindamycin and ceftriaxone initiated • Within 36 h of admission develoPs dyspnea/hypoxia • Transferred to PICU at tertiary care medical center 7 7 Case 1: Color Me Bad • Patient intubated for imPending respiratory failure and Progressive shock • Physical examination revealed two large, indurated abscesses on buttocks • MultiPle Pustules on chest, abdomen, and extremities: concern for staPhylococcal infection or ecthyma 8 Richard et al., 2015 Am J Case Rep 16:740-4 8 4 10/11/19 Case 1: Color Me Bad • DeveloPed acute respiratory distress syndrome • Placed on venoarterial extracorPoreal membrane oxygenation (ECMO) to maximize cardiac outPut • Antimicrobial coverage: vancomycin, clindamycin, nafcillin (for Presumed staPhylococcal infection) • Rare Gram-negative rods (GNR) observed in wound Gram stain • Ceftriaxone added based on wound Gram stain result; later changed to meroPenem because of Patient’s decomPensation 9 9 Case 1: Color Me Bad • Wound/blood cultures grew a GNR • Grew on blood agar (BAP) à violet pigmentation Gram stain: medium sized GNR Violet-colored colonies on BAP 10 Image credit: https://www.cdc.gov/microbenet/ 10 5 10/11/19 Case 1: Color Me Bad • Chromobacterium violaceum • Treated with meroPenem, IV ciProfloxacin and IV trimethoPrim- sulfamethoxazole (SXT) – all low MIC values (theraPy Paired to meroPenem and ciProfloxacin once antibiotic suscePtibility data available) • Discharged on day 40 on ertapenem (?) and PO SXT • After ~4 mo of theraPy, ESR mildly elevated, continued on PO ciProfloxacin and SXT for a total of 6 mo theraPy • DeveloPed autoamputation of distal end of right thumb and several toes, required skin graft of dorsum of right foot • Returned to school 4 mo after initial illness, no other Permanent sequelae 11 11 Case 1: Color Me Bad • Diagnosed with chronic granulomatous disease (CGD) • c.75-76delGT mutation in NCF1 gene (NCF1 encodes a subunit of the Phagocyte NADPH oxidase) • Past medical history of submental abscess at 2 yrs that grew Nocardia spP, suPPorts diagnosis of CGD 12 12 6 10/11/19 C. violaceum: Clinical Significance • Inhabits soil/water in troPical/subtroPical climates • Clinical Presentation (entry through skin [rarely oral]): - Localized infection (wound infections) - Disseminated infection, sePsis • Endowed with numerous virulence factors: adhesins, invasins, cytolytic proteins • Associated with CGD/glucose-6-Phosphate dehydrogenase deficiency à high mortality rate 13 13 Chronic Granulomatous Disease • An inherited immunodeficiency disorder: inability of Phagocytes to kill microbes they have ingested (usually discovered early in childhood) • Recurrent infection (every 3 to 4 yrs) of lung, skin, lymPh nodes, and liver (granulomatous inflammation of affected organs) • CGD infections caused by (catalase POS [environmental] organisms): - Aspergillus spP - Nocardia spP - S. aureus - (Pigmented) Gram-negatives: C. violaceum, Burkholderia cepacia comPlex, Serratia marcescens, and Pseudomonas aeruginosa • Defective enzyme in Phagocytes - NADPH oxidase complex - results in imPaired Production of reactive oxygen species (ROS), in Phagocytes • ROS kill microbes à thus lower levels of ROS leads to decreased microbial killing 14 14 7 10/11/19 Relationship between CGD and Catalase- Positive Organisms Human NADPH oxidase complex - + + NADPH + 2O2 à 2O2 + NADP + H Human Superoxide dismutase + - 2H + 2O2 à H2O2 + O2 Bacterial Catalase 2H2O2 à 2H2O + O2 15 15 Relationship between CGD and C. violaceum in the SE USA 16 Macher et al., 1982 Ann Intern Med 97:51-5 16 8 10/11/19 C. violaceum: Microbiology • Motile GNR, glucose-fermenter (non-lactose-fermenter) • Facultative anaerobe • Cultures have almond-like odor (ammonium cyanide) • Pigmented (~90%) and non-Pigmented (~10%) strains • Oxidase (OX) POS/indole (IND) variable (V) - Non-Pigmented strains typically IND POS • Non-Pigmented strains can be confused with Aeromonas spP and Vibrio spP (automated systems can misidentify as Burkholderia pseudomallei) 17 17 C. violaceum: Microbiology Vibrio spp: Aeromonas spp: - OX, POS - OX, POS - IND, POS - IND, POS - Lysine decarboxylase, POS - Violet Pigmentation, NEG (excePt, A. caviae comPlex) - TCBS growth, POS - TCBS growth, NEG C. violaceum: - OX, POS - IND, V - Lysine decarboxylase, NEG - Violet Pigmentation, V - Almond-like odor - TCBS growth, NEG 18 Image credit: Selma Salter, Stamford Health 18 9 10/11/19 C. violaceum: Microbiology Aeromonas spp: Vibrio spp: - OX, POS - OX, POS - IND, POS - IND, POS - Lysine decarboxylase, POS - Violet Pigmentation, NEG (excePt, A. caviae comPlex) - TCBS growth, POS - TCBS growth, NEG C. violaceum: - OX, POS - IND, V - Lysine decarboxylase, NEG - Violet Pigmentation, V - Almond-like odor - TCBS growth, NEG 19 Image credit: Selma Salter, Stamford Health 19 Oxidase Activity of Pigmented Strains: Ascending Paper Chromatography Inset bottom of filter Filter PaPer paper in petri dish Organism Schmear Petri dish filled with 2-10 mL oxidase reagent (TMPD) Dhar and Johnson, 1973 J Clin Pathol 26:304-6 20 Slesak et al., 2009 Ann Clin Microbiol Antimicrob 8:24 20 10 10/11/19 Oxidase Activity of Pigmented Strains: Ascending Paper Chromatography - + + Product of reaction (indoPhenol blue) Filter PaPer “wicks” uP PaPer Petri dish filled with 2-10 mL oxidase reagent (TMPD) Dhar and Johnson, 1973 J Clin Pathol 26:304-6 21 Slesak et al., 2009 Ann Clin Microbiol Antimicrob 8:24 21 Testing Oxidase Activity of Pigmented C. violaceum Strains E. coli C. violaceum P. aeruginosa - + + Distilled water (2-10 mL) Schmear of organism 1% TMPD (oxidase reagent, 2-10 mL) Schmear of organism Dhar and Johnson, 1973 J Clin Pathol 26:304-6 22 Slesak et al., 2009 Ann Clin Microbiol Antimicrob 8:24 22 11 10/11/19 C. violaceum: Antibiotic Susceptibility • No established breakpoints for AST results • High MIC values: Polymyxins/some b-lactams • Low MIC values: fluoroquinolones, tetracyclines, SXT 23 McAuliffe et al., 2015 Am J Trop Med Hyg 92:605-10 23 Color Me Bad: Violacein • Ethanol-soluble violet Pigment • Two molecules of L-tryptoPhan à Pyrrolidone scaffold • Role in evading the immune system: - Neutralization of ROS - Induce aPoPtosis of leukocytes (Potential chemotheraPy) • Strong antimicrobial activity against bacteria/Protozoa 24 Image credit: LoPes et al., 2009 Antimicrob Agents Chemother 53:2149-52 24 12 10/11/19 Case 2: Look What the Dog Dragged In • 4-year-old dog (mixed breed) • Rescue recently imPorted from Thailand • Paralyzed hind legs (spinal injury), urinary incontinence • Urine culture requested because of incontinence Case Courtesy of K. Deriziotis, J. Moody, D. Peck, R. Franklin-Guild, and A. Thachil College of Veterinary Medicine, Animal Health Diagnostic Center, Cornell University 25 Image credit: httP://www.handicaPPedPets.com/blog/ 25 Case 2: Look What the Dog Dragged In • Urine Culture: - 24 h: >105 PinPoint colonies on BAP and eosin methylene blue agar (EMB) - 48 h: mucoid colonies on BAP and EMB (NLF) • MALDI-TOF MS (Bruker), Burkholderia thailandensis (≥2.00) • Culture immediately moved to BSL-3 facility 26 Image credit: Cornell University, AHDC 26 13 10/11/19 Case 2: Look What the Dog Dragged In • “PresumPtive B. pseudomallei” NYS DOH PHL Biodefense Laboratory (determined by PCR) • Confirmed as an atypical strain of B. pseudomallei at CDC • Atypical characteristics: - Beta-hemolytic on BAP at 48 h (sometimes observed around areas of confluent growth, not around individual colonies) - Catalase NEG – unusual! • Tier 1 select agent; Federal Select Agent Program 27 httPs://www.selectagents.gov/ohP-app1.html 27 B. pseudomallei: Clinical Significance • Agent of human/animal melioidosis (~165,000 cases yr/worldwide) • Endemic in SE Asia, N Australia, India, China, Caribbean (Puerto Rico) - troPical areas: case fatality rate estimated as high as 50%! • Environmental organism, resident in soil/water • Infection is seasonal, uP to 85% of cases during monsoon wet season • Severe weather events/environmental disturbances have been associated with clusters (e.g., Asian tsunami 2004) 28 28 14 10/11/19 B. pseudomallei:

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    39 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us